Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Non Operating Income: 2016-2025

Historic Non Operating Income for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to $1.7 million.

  • Assembly Biosciences' Non Operating Income rose 25.61% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 20.55%. This contributed to the annual value of $5.6 million for FY2024, which is 61.49% up from last year.
  • Latest data reveals that Assembly Biosciences reported Non Operating Income of $1.7 million as of Q3 2025, which was up 88.49% from $895,000 recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Non Operating Income peaked at $1.7 million during Q3 2025, and registered a low of $58,000 during Q1 2021.
  • Moreover, its 3-year median value for Non Operating Income was $1.1 million (2025), whereas its average is $1.2 million.
  • Per our database at Business Quant, Assembly Biosciences' Non Operating Income tumbled by 94.42% in 2021 and then soared by 171.26% in 2024.
  • Assembly Biosciences' Non Operating Income (Quarterly) stood at $101,000 in 2021, then reached $1.6 million in 2023, then slumped by 30.89% to $1.1 million in 2024, then increased by 25.61% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $895,000 for Q2 2025, and $1.1 million during Q1 2025.